| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Block | Real Estate Real Estate Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $112.56M | Series C | 10/9/2021 | $55M | $301.83M | $8.30 | Giant Ventures, NEA, Morningside, Lerer Hippeau, Obvious Ventures, Rainfall Ventures, Firstminute Capital, BoxGroup, SV Angel, Kelly Wearstler, Ann Sacks, Eric Wu, Oisin Hanrahan, Spencer Rascoff | ||||
 | CallMiner | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $164.71M | Series D-4 | 5/30/2025 | $7.5M | $336.29M | $6.30 | Undisclosed Investors | ||||
 | Calysta | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $162M | Senior Series D-1 | 9/10/2021 | $34.5M | $334.61M | $0.66 | Adisseo, Aqua-Spark, WTI, BP Ventures | ||||
 | CandidPro | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $144.62M | Series A-1 | 7/11/2023 | $7.71M | $261.94M | $1.23 | Venrock, F-Prime | ||||
 | Capella Space | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $348.19M | Series C-4 | 2/7/2025 | $100M | $437.93M | $2.29 | Undisclosed Investors | ||||
 | Catalyst | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $66.86M | Series B-1 | 3/31/2022 | $21.46M | $247.6M | $17.93 | UndisclosedInvestors | ||||
 | Causal Labs | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $76.23M | Series A-2 | 11/25/2025 | $38.09M | $337.82M | $18.78 | Undisclosed Investors | ||||
 | Certify | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70.45M | Series B | 6/26/2025 | $40M | $271.73M | $13.23 | Transformation Capital, General Catalyst, Upfront Ventures, SemperVirens Venture Capital | ||||
 | Coalesce | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $79.12M | Series B-3 | 4/4/2024 | $12.08M | $224.9M | $9.35 | Industry Ventures, Emergence Capital, 11.2 Capital, Bob Muglia, DNX Ventures, GreatPoint Ventures, Hyperlink Ventures, Next Legacy Partners, Snowflake Ventures, Telstra Ventures | ||||
 | Cooler Heads | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $23.97M | Series A-3 | 7/10/2026 | $3.27M | $34.04M | $1.15 | Undisclosed Investors | ||||
 | Covera Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $180.66M | Series C-3 | 4/10/2026 | $27.35M | $179.98M | $1.74 | Undisclosed Investors | ||||
 | Edge Delta | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $84M | Series B | 5/3/2022 | $66M | $427.24M | $4.12 | Quiet Capital, BAM Elevate, Earlybird Digital East, Geodesic Capital, Kin Ventures, ServiceNow, Cisco Investments, Menlo Ventures, MaC Venture Capital, Amity Ventures | ||||
 | Element Science | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $115.7M | Series C-2 | 3/3/2020 | $51.3M | $198.27M | $1.09 | Deerfield Healthcare, Qiming Venture Partners, Cormorant Asset Management, Invus Opportunities, Third Rock Ventures, GV | ||||
 | Elveo Mobile | Missing Missing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20M | Series A | 8/17/2026 | $20M | $403.11M | $10.00 | Nelco | ||||
 | Embroker | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $162.96M | Series D | 12/20/2024 | $18M | $369.84M | $3.66 | Undisclosed Investors | ||||
 | Envelop Risk | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $130M | Series B | 9/14/2021 | $130M | $359.56M | $1.53K | SoftBank | ||||
 | Eureka Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $130.85M | Series E | 12/16/2019 | $45M | $359.7M | $4.16 | Lyell Immunopharma, Acorn Pacific Ventures, GP Capital, Suma Venture, Harbinger Venture Capital, Yuan Capital, Majuven | ||||
 | Evommune | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $268.46M | Series C | 10/31/2024 | $115.5M | $346.35M | $1.59 | RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management | ||||
 | ExecOnline | Education E-Learning | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $138.53M | Series E-2 | 3/12/2026 | $33.73M | $327.35M | $6.36 | JS Partners, Newspring Capital, ABS Capital Partners, Osage Ventures | ||||
 | Fevo | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $106.23M | Series C-1 | 12/12/2022 | $16.59M | $296.68M | $1.15 | Undisclosed Investors | ||||
 | Fortera | Industrial Construction | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $215.17M | Series C-1 | 8/20/2024 | $40M | $350.48M | $36.06 | NOVA by Saint-Gobain, Temasek, Khosla Ventures, Wollemi Capital, Presidio Ventures, Alumni Ventures | ||||
 | Foundry Robotics | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119M | Series A-1 | 10/28/2026 | $100M | $499.29M | $30.58 | -- | ||||
 | Gameto | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $117M | Series C | 8/12/2025 | $44M | $234.3M | $7.31 | Overwater Ventures, Insight Partners, RA Capital, Two Sigma Ventures, BOLD Capital Partners, Future Ventures, Ingeborg Investments, Arcadia Investment Partners, PAGS Group, Pontiva Healthcare Partners, Portfolia | ||||
 | Good Eggs | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $358.11M | Series DD | 3/23/2023 | $7M | $22.04M | $0.62 | Glade Brook Capital | ||||